AndreCKalilMD

PubMed

• True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group.
  Robert L Gottlieb, Andre C Kalil> ;Clinical Infectious Diseases. 2024 Mar 29
• Challenges for a broad international implementation of the current severe community-acquired pneumonia guidelines.
  Jorge I F Salluh, Pedro Póvoa, Abi Beane, Andre Kalil, Cornelius Sendagire, Daniel A Sweeney, David Pilcher, Eva Polverino, Evelina Tacconelli, Elisa Estenssoro, Jean-...> ;Intensive Care Medicine. 2024 Mar 28
• Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
  Siempos, I., Kalil, A., Belhadi, D., Veiga, V., Cavalcanti, A., Branch-Elliman, W., Papoutsi, E., Gkirgkiris, K., Xixi, N., Kotanidou, A., Hermine, O., Porcher, R., Ma...> ;Eclinicalmedicine. 2024 Mar 1
• Management of Ventilator-Associated Pneumonia: Guidelines.
  Metersky, M., Kalil, A.> ;Infectious Disease Clinics of North America. 2024 Mar 1
• Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study.
  Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas Oppelt, Mark Berry, Alpesh N Amin> ;Journal of Comparative Effectiveness Research. 2024 Apr 1
• Racial and Ethnic Disparities in COVID-19 Treatments in the United States.
  Mozaffari, E., Chandak, A., Gottlieb, R., Sarda, V., Berry, M., Brown, G., Amin, A., Kalil, A., Okulicz, J., Chima-Melton, C.> ;Journal of Racial and Ethnic Health Disparities. 2024 Feb 26
• 1 citations
  Choosing immunomodulating therapies for the treatment of COVID-19: recommendations based on placebo-controlled trial evidence.
  Lobo, S., Póvoa, P., Sweeney, D., Kalil, A.> ;Clinical Microbiology and Infection. 2024 Jan 3
• A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Inf...
  Arns, B., Horvath, J., Rech, G., Sesin, G., Agani, C., da Rosa, B., Dos Santos, T., Brochier, L., Cavalcanti, A., Tomazini, B., Pereira, A., Veiga, V., Nascimento, G.,...> ;Infectious Diseases and Therapy. 2024 Jan 1
• 5 citations
  Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice.
  Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Stephanie H Read, Heng Jiang, Mel Chiang, EunYoung Lee, Rikisha Gupta, Mark Berry, Andre C Kalil> ;Clinical Infectious Diseases. 2023 Dec 15
• 1 citations
  Society of Critical Care Medicine and the Infectious Diseases Society of America Guidelines for Evaluating New Fever in Adult Patients in the ICU.
  Naomi P O'Grady, Earnest Alexander, Waleed Alhazzani, Fayez Alshamsi, Jennifer Cuellar-Rodriguez, Brian K Jefferson, Andre C Kalil, Stephen M Pastores, Robin Patel, Da...> ;Critical Care Medicine. 2023 Nov 1
• Executive Summary: Guidelines for Evaluating New Fever in Adult Patients in the ICU.
  Naomi P O'Grady, Earnest Alexander, Waleed Alhazzani, Fayez Alshamsi, Jennifer Cuellar-Rodriguez, Brian K Jefferson, Andre C Kalil, Stephen M Pastores, Robin Patel, Da...> ;Critical Care Medicine. 2023 Nov 1
• 1 citations
  Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper.
  Chanu Rhee, Jeffrey R Strich, Kathleen Chiotos, David C Classen, Sara E Cosgrove, Ron Greeno, Emily L Heil, Sameer S Kadri, Andre C Kalil, David N Gilbert, Henry Masur...> ;Clinical Infectious Diseases. 2024 Mar 20
• 4 citations
  Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants.
  Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Stephanie H Read, EunYoung Lee, Celine Der-Torossian, Rikisha Gupta, Mark Berry, Stijn Hollem...> ;Open Forum Infectious Diseases. 2023 Oct 1
• Impact of the COVID-19 pandemic on non-COVID-19 community-acquired pneumonia: a retrospective cohort study.
  Terry Lee, Keith R Walley, John H Boyd, Kelly A Cawcutt, James A Russell, Andre Kalil> ;BMJ Open Respiratory Research. 2023 Oct 1
• Which trial do we need? One or two antimicrobials with anti-pseudomonal activity for the empirical treatment of Ventilator-associated pneumonia due to Gram-negative ba...
  Erlangga Yusuf, Alexandre P Zavascki, Henrik Endeman, Andre C Kalil> ;Clinical Microbiology and Infection. 2023 Aug 11
• 1 citations
  Vitamin C and Sepsis: Is Bayesian Reanalysis Useful to Translate the Results of Frequentist Randomized Trials?
  Andre C Kalil, Steven Q Simpson> ;Critical Care Medicine. 2023 Aug 1
• 2 citations
  Translating Clinical Trial Results to Clinical Practice During a Pandemic.
  Andre C Kalil, Angela Huttner, Carlos A Gomez> ;JAMA. 2023 Jul 25
• Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.
  Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg, Jing Wang, Jennifer A Whitaker, Christopher J Colombo, Seema U Nayak,...> ;Open Forum Infectious Diseases. 2023 Jun 1
• 2 citations
  Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections.
  Daniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, John H Beigel, Tatiana Beresnev, Valeria D Cantos, Jose G Castro, Stuart H Cohen, Kaitlyn Cross, Lori E Dodd, Nat...> ;Open Forum Infectious Diseases. 2023 May 1
• Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia.
  Ryan C Maves, Andre C Kalil> ;Clinical Microbiology and Infection. 2023 Jun 1
• Remdesivir saves lives. Were 3 years needed to learn that?
  Andre C Kalil> ;The Lancet. Respiratory Medicine. 2023 May 1
• 38 citations
  How to use biomarkers of infection or sepsis at the bedside: guide to clinicians.
  Pedro Póvoa, Luís Coelho, Felipe Dal-Pizzol, Ricard Ferrer, Angela Huttner, Andrew Conway Morris, Vandack Nobre, Paula Ramirez, Anahita Rouze, Jorge Salluh, Mervyn Sin...> ;Intensive Care Medicine. 2023 Feb 1
• 3 citations
  Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial.
  Michael Waters, James A McKinnell, Andre C Kalil, Greg S Martin, Timothy G Buchman, Wiebke Theess, Xiaoying Yang, Annemarie N Lekkerkerker, Tracy Staton, Carrie M Rose...> ;Critical Care Medicine. 2023 Jan 1
• 2 citations
  Adjunctive Rifampin Following Debridement and Implant Retention for Staphylococcal Prosthetic Joint Infection: Is it Effective if not Combined With a Fluoroquinolone?
  Nicolás W Cortés-Penfield, Angela L Hewlett, Andre C Kalil> ;Open Forum Infectious Diseases. 2022 Dec 1
• Preparing the Intensive Care Unit for a Lethal Viral Respiratory Pandemic.
  Kelly Cawcutt, Andre C Kalil, Angela Hewlett> ;Infectious Disease Clinics of North America. 2022 Dec 1
• Join now to see all